2022-2029 年全球醫療保健分析市場
市場調查報告書
商品編碼
1153769

2022-2029 年全球醫療保健分析市場

Global Healthcare Analytics Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計在預測期內(2022 年至 2029 年),醫療保健分析市場規模將以 11.7% 的複合年增長率增長。

醫療保健分析會仔細檢查現有的和記錄在案的行業數據,以預測趨勢、擴大外展範圍,甚至更好地管理疾病的傳播。醫療保健分析涵蓋了廣泛的企業領域,並提供了對宏觀和微觀層面的理解。探索如何提高患者護理質量、臨床數據、診斷和業務管理。

市場動態

全球醫療保健分析市場的主要驅動力是對醫療保健數據分析的需求不斷增長、新產品發布、慢性病患病率上升、移動技術和互聯網的使用增加以及人口健康管理。對醫療保健數據分析的需求不斷增長

醫療保健領域對數據分析日益增長的需求以及新產品的推出正在推動全球醫療保健分析市場的增長。

對醫療保健數據管理日益增長的需求正在推動全球醫療保健分析市場的增長。醫療行業相關的數據分析和管理,由於大量詳細複雜的數據湧入,沒有特定的工具是很難處理的,這是最難做的事情之一,因為你無法提取關鍵實現幫助你轉變。為此,需要能夠將海量醫療數據轉化為重要信息的分析工具,改善為患者提供的醫療服務,提高醫療機構的效率。根據一項調查,超過 90% 的醫療保健組織同意數據分析對醫療保健的影響。

此外,新數據管理解決方案的開發正在推動全球醫療保健分析市場的增長。例如,2022 年 8 月,為基於價值的護理提供支持的領先人工智能平台 Apicio 將加速對集中醫療記錄的實時數據訪問、醫療記錄和審計文件的搜索,以及基於價值的預測護理計劃的加速。基於價值的護理計劃。宣布推出 Apcare ChartSpace,這是一種醫療數據管理解決方案,可讓臨床行動洞察浮出水面。

數據安全問題和成本阻礙了全球醫療保健分析市場的增長。

但是,數據安全問題和分析解決方案的成本將阻礙全球醫療保健分析市場的增長。例如,由於黑客攻擊和安全漏洞不斷,數據安全風險很高,對醫療保健公司來說代價高昂,未經事先批准就披露患者數據被證明是不道德的。此外,數據分析工具和服務需要許可證和訂閱,給組織帶來財務負擔。

COVID-19 的影響

隨著大數據工具在醫療保健決策中變得越來越重要,疫情對全球醫療保健分析市場產生了積極影響。醫療保健機構、WHO 等監管機構和 NIH 已通過預測模型與大流行作鬥爭,以幫助分配資源、預測激增、改善患者護理和結果並採取預防措施。隨著數據的不斷湧入,分析這些健康數據使我們能夠更理性地理解如何治療和治療患者。因此,大流行提高了人們對數據分析在醫療保健中重要性的認識,促進了醫療保健分析的使用,並對市場產生了積極影響。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 醫療保健領域對數據分析的需求不斷增長
      • 市場策略
    • 約束因素
      • 安全問題
      • 高許可成本
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章(按組件)

  • 軟件
  • 硬件
  • 服務

第八章應用

  • 臨床管理
  • 財務管理
  • 運營管理
  • 人口健康管理

第9章副產品

  • 描述性的
  • 預測類型
  • 說明性的

第 10 章最終用戶

  • 診所
  • 醫院
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準

第13章公司簡介

  • McKesson
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • IBM
  • OptumHealth
  • Oracle
  • Verisk Analytics
  • Centene
  • MedeAnalytics
  • Enlitic
  • Allscripts Healthcare Solutions
  • Cerner

第14章 DataM

簡介目錄
Product Code: DMHCIT250

Market Overview

Healthcare Analytics Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11.7% during the forecast period (2022-2029).

Healthcare analytics scrutinizes existing and documented industry data to forecast trends, enhance outreach, and even sufficiently manage the spread of diseases. Healthcare analytics encompasses a wide spectrum of enterprises, offering to understand the macro and micro levels. It reveals ways to improve patient care quality, clinical data, diagnosis, and business management.

Market Dynamics

The major driving forces for the global healthcare analytics market are the growing need for healthcare data analysis, new product launches, the rising prevalence of chronic diseases, the increasing use of mobile technology and the internet, and the increasing demand for population health management.

The growing need for data analytics in healthcare and new product introductions is boosting the global healthcare analytics market growth.

The growing need for healthcare data management is fueling the global healthcare analytics market as far as data analytics and management concerning the healthcare industry is among the most challenging as there is a massive influx of detailed and complicated data, which makes it scary to handle in the absence of particular tools which in turn results in the disability to extract significant perception that can help in improving the healthcare service quality provided to the patients and improve the efficacy of the healthcare organization. Therefore, there is a great need for analytical tools to transform vast healthcare data into important information, which, in turn, improves the healthcare services offered to the patient and healthcare organization efficacy. As per a survey, more than 90% of healthcare organizations consented to the impact of data analytics in healthcare.

Furthermore, new data management solution development drives growth in the global healthcare analytics market. For instance, in August 2022, Apixio, a leading AI platform that powers value-based care, introduced Apicare ChartSpace, a health data management solution providing real-time data access to centralized medical charts, accelerated chart and audit file retrieval, also enabling the surfacing of probable action insights across value-based care programs.

The data security concerns and costs will hamper the global healthcare analytics market growth.

However, the analytical solutions' data security concerns and costs will hamper the growth of the global healthcare analytics market. For instance, with constant hacking and security violations, there are high data security risks, which will prove costly to healthcare companies and unethical to disclose patient data without prior authorization. Furthermore, data analytic tools and services will require licensing or subscription, creating a financial burden on the organization.

COVID-19 Impact

The pandemic positively impacted the global healthcare analytics market since big data tools have become increasingly important in healthcare decision-making. It helped healthcare providers, regulatory bodies like WHO, and NIH fight against the pandemic via predictive models to help allocate resources, predict surges, improve patient care and outcomes and employ preventive measures. As data influx was at a near-constant rate, analyzing that health data has enabled a more reasonable understanding of ways to respond to and treat patients. Thus, the pandemic has made us realize the importance of data analytics in healthcare and promoted the use of healthcare analytics, positively impacting the market.

Segment Analysis

Software solutions for healthcare analytics are expected to grow at the fastest CAGR during the forecast period (2022-2029).

Healthcare analytics software is expected to grow at the fastest CAGR during the forecast period (2022-2029) as software solutions do not require new infrastructure than existing for installation and can be easily accessed from anywhere on the device compared to the healthcare hardware analytic solution, which requires infrastructure for installation and can not be accessed from anywhere else. The construction of new infrastructure increases financial spending. Furthermore, introducing software analytics with AI has ensured the dominance of software healthcare analytical solutions over the global healthcare analytics market. For instance, in January 2020, MORE Health, a global healthcare company, introduced a new Artificial Intelligence (AI) feature on MORE Health's Physician Collaboration Platform, benefiting both the physician and patient sides of the platform. Therefore, from the mentioned data, software solutions for healthcare analytics are predicted to dominate the global market during the forecast period.

Geographical Analysis

North America holds the largest share of the global healthcare analytics market.

The North American region retains a large share of global healthcare analytics and is estimated to continue to retain it in the forecast period (2022-2029). Most of the key market players are based in the United States and have a large stake in the global healthcare analytics market through different market tactics such as collaborations, product launches, acquisitions, partnerships and many others. For instance, in October 2022, Enlitic, a leading healthcare IT company, partnered with MULTI Inc., a healthcare technology provider of authentic parts, equipment, and services. The partnership is aimed to bring the Enlitic Curie platform to healthcare providers across the U.S., helping the radiology departments drive operational improvements. Also, in December 2020, Centene, a leading multi-national healthcare enterprise, acquired Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions to make sense of unstructured clinical data for its millions of members. Apixio operates independently underneath Centene's Health Care Enterprises group. Therefore, as per the data above, it is estimated that North America will dominate the global healthcare analytics market throughout the forecast period.

Competitive Landscape

The key players operating in the global healthcare analytics market are IBM, OptumHealth, Oracle, Verisk Analytics, Centene, MedeAnalytics, McKesson, Enlitic, Allscripts Healthcare Solutions, and Cerner. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the healthcare analytics market globally. For instance, in March 2021, McKesson Corporation introduced ScriptPAS, a pharmacy management platform for oncology practices.

McKesson Corporation

Overview:

McKesson Corporation is a Texas, United States-based company founded in 1833. American company business deals with distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. McKesson Corporation delivers the third of all pharmaceuticals used in North America.

Product Portfolio:

McKesson Corporation's product portfolio for healthcare analytics has McKesson Business AnalyticsSM: Which provides actionable insights and detailed reporting necessary to help manage the business through identifying savings opportunities, correcting inefficiencies, increasing ordering compliance and building resilience in the supply chain.

The global healthcare analytics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Need for Data Analytics in Healthcare
      • 4.1.1.2. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Security Concerns
      • 4.1.2.2. High Licensing Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Components

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 7.1.2. Market Attractiveness Index, By Components
  • 7.2. Software
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Hardware
  • 7.4. Services

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Clinical Management
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Financial Management
  • 8.4. Operations Management
  • 8.5. Population Health Management

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. Descriptive
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Predictive
  • 9.4. Prescriptive

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Hospital
  • 10.4. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. McKesson
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. IBM
  • 13.3. OptumHealth
  • 13.4. Oracle
  • 13.5. Verisk Analytics
  • 13.6. Centene
  • 13.7. MedeAnalytics
  • 13.8. Enlitic
  • 13.9. Allscripts Healthcare Solutions
  • 13.10. Cerner

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us